|
US2005176650A1
|
|
Stable parenteral formulation of levomepromazine and a method for stabilizing said formulation
|
|
US2005080076A1
|
|
N-desmethyl levomepromazine
|
|
US2005065175A1
|
|
Oral transmucosal methadone
|
|
US2005025825A1
|
|
Tranexamic acid formulations with reduced adverse effects
|
|
AU2003229091A1
|
|
Enteric coated caffeine tablet
|
|
US2003194374A1
|
|
Compositions including a visual marker and method of use thereof
|
|
US2004180915A1
|
|
Methadone-containing compositions for parenteral administration and method of use thereof
|
|
US2004039430A1
|
|
System and method using the rectal mucosal membrane for inducing hypothermia and warming
|
